Webcast - Live Q2 2012 Array BioPharma Inc. Financial Results Conference Call 01/31/12 at 9:00 a.m. ET Profile Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas.

Stock Quote ARRY (Common Stock) Exchange NASDAQ (US Dollar) Price $2.38 Change (%)   0.07 (3.03%) Volume 241,967 Data as of 01/27/12 4:00 p.m. ET Minimum 20 minute delay Refresh quote

Receive E-mail Alerts

RSS Feeds

Recent News

More >>

01/23/12 Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2012 on January 30, 2012 01/16/12 Array BioPharma's Chief Executive Officer Robert E. Conway Resigns 01/04/12 Array BioPharma to Present at the 30th Annual J.P. Morgan Healthcare Conference 12/11/11 ARRY-614 Demonstrates Positive Single Agent Activity in Patients with Myelodysplastic Syndromes

Upcoming Events

More >>

Date Title 01/31/12 9:00 a.m. ET Q2 2012 Array BioPharma Inc. Financial Results Conference Call

Primary IR Contacts Michael Carruthers Chief Financial Officer Phone: (303) 381-6663 E-mail: Michael.Carruthers@arraybiopharma.com Tricia Haugeto Manager, Communications Phone: (303) 386-1193 E-mail: Tricia.Haugeto@arraybiopharma.com	Transfer Agent American Stock Transfer and Trust Company 59 Maiden Lane Plaza Level New York, NY 10038 Phone: (800) 937-5449 Fax: (718) 236-4588 E-mail: Info@amstock.com Website: http://www.amstock.com
Legal Gross Hartman LLC 1877 Broadway, Suite 601 Boulder, CO 80302 Phone: (303) 926-4823	Accountants KPMG LLP 707 Seventeenth Street, Suite 2700 Denver, CO 80202 Phone: (303) 295-5572

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.